📰 Achv News
Page 2 - Achv News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Achv. Real-time updates on events, politics, business and more.
May 31, 2023
Achieve Life Sciences, Inc. (NASDAQ:ACHV – Get Rating) was the target of a significant growth in short interest in the month of May. As of May 15th, there was short interest totalling 633,200 shares, a growth of 11.2% from the April 30th total of 569,600 shares. Based on an average daily trading volume, of 156,300 […]
May 17, 2023
Achieve Life Sciences, Inc. (NASDAQ:ACHV – Get Rating) – Stock analysts at Zacks Small Cap issued their Q2 2023 earnings per share estimates for shares of Achieve Life Sciences in a research note issued on Wednesday, May 10th. Zacks Small Cap analyst J. Vandermosten forecasts that the biopharmaceutical company will earn ($0.40) per share for […]
May 13, 2023
Achieve Life Sciences (NASDAQ:ACHV – Get Rating) and Virax Biolabs Group (NASDAQ:VRAX – Get Rating) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, valuation, risk, analyst recommendations, earnings, dividends and institutional ownership. Earnings & Valuation This table compares Achieve […]
April 28, 2023
Achieve Life Sciences, Inc. (NASDAQ:ACHV – Get Rating) shares crossed above its two hundred day moving average during trading on Tuesday . The stock has a two hundred day moving average of $4.08 and traded as high as $8.12. Achieve Life Sciences shares last traded at $8.02, with a volume of 73,152 shares changing hands. […]
April 19, 2023
Achieve Life Sciences, Inc. (NASDAQ:ACHV – Get Rating)’s share price passed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $3.91 and traded as high as $7.80. Achieve Life Sciences shares last traded at $7.80, with a volume of 119,644 shares. Analysts Set New Price Targets […]
April 17, 2023
Achieve Life Sciences (NASDAQ:ACHV – Get Rating) and Cardio Diagnostics (NASDAQ:CDIO – Get Rating) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, valuation, dividends, risk, profitability, analyst recommendations and institutional ownership. Valuation and Earnings This table compares Achieve Life […]
May 16, 2022
Achieve Life Sciences, Inc. (NASDAQ:ACHV – Get Rating) was the recipient of a large increase in short interest in April. As of April 30th, there was short interest totalling 426,700 shares, an increase of 36.7% from the April 15th total of 312,200 shares. Based on an average daily volume of 84,900 shares, the short-interest ratio […]
May 14, 2022
Achieve Life Sciences (NASDAQ:ACHV – Get Rating) released its quarterly earnings data on Thursday. The biopharmaceutical company reported ($0.80) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.89) by $0.09, MarketWatch Earnings reports. During the same quarter last year, the firm posted ($1.30) EPS. Shares of Achieve Life Sciences stock opened at […]
May 14, 2022
Achieve Life Sciences (NASDAQ:ACHV – Get Rating) issued its quarterly earnings data on Thursday. The biopharmaceutical company reported ($0.80) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.89) by $0.09, MarketWatch Earnings reports. During the same quarter last year, the firm earned ($1.30) EPS. Achieve Life Sciences stock opened at $6.64 […]
April 22, 2022
Wall Street brokerages expect Achieve Life Sciences, Inc. (NASDAQ:ACHV – Get Rating) to report earnings per share (EPS) of ($0.89) for the current quarter, according to Zacks. Zero analysts have made estimates for Achieve Life Sciences’ earnings. Achieve Life Sciences reported earnings of ($1.30) per share during the same quarter last year, which would suggest […]